BSE filing, NSE: DEEP. Summary written from the filing by ALFA Finder's alert engine.
Deep Polymers Ltd: key numbers
- Share price
- ₹39.49
- Market cap
- ₹95.49 Cr
- Revenue (annual)
- ₹98.72 Cr
- Net profit (annual)
- ₹6.78 Cr
- P/E (TTM)
- 7.6×Sector 34.5×
- Promoter holding
- 66.10%+0.22% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deep Polymers Ltd
All →Deep Polymers Board Meeting Date
Deep Polymers intimates a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for Q2 and H1 FY27. The filing is an advance notice; the agenda is proposed and no results are yet approved.
Deep Polymers Fund Raise of ₹3.2 Cr
Deep Polymers Ltd's board approved issuing 32 lakh equity warrants worth ₹3.20 Crore on a preferential basis to 14 investors, subject to shareholder approval.
- Value
- ₹3.20 Cr
Deep Polymers Board Meeting Date
Deep Polymers Ltd scheduled a board meeting for October 10, 2026, to consider a proposal for issuing equity shares and warrants via preferential allotment.
Deep Polymers Annual General Meeting
Deep Polymers Ltd held its 21st Annual General Meeting on September 30, 2026, to transact business including the adoption of financial statements and director appointments.
Deep Polymers Annual Report
Deep Polymers Ltd has filed its Annual Report for the financial year 2025-26 as required under SEBI regulations. The document is available on the company's website.
Deep Polymers Annual General Meeting
Deep Polymers Ltd issued the Notice for its 21st Annual General Meeting scheduled for the financial year 2026-27. The document outlines the agenda and voting details.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.